Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc-Alexander Ohlow

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
JACC. Cardiovascular Interventions|August 20, 2021
Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents: The BASKET-SMALL 2 TrialJochen Wöhrle, Bruno Scheller, Julia Seeger, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 30, 2020
Drug-coated balloon versus drug-eluting stent in small coronary artery lesions: angiographic analysis from the BASKET-SMALL 2 trialGregor Fahrni, Bruno Scheller, Michael Coslovsky, et al.
Circulation. Cardiovascular Interventions|January 10, 2022
Safety and Efficacy of Drug-Coated Balloons Versus Drug-Eluting Stents in Acute Coronary Syndromes: A Prespecified Analysis of BASKET-SMALL 2Norman Mangner, Ahmed Farah, Marc-Alexander Ohlow, et al.
Cardiovascular Drugs and Therapy|April 20, 2022
Results from the "Me & My Heart" (eMocial) Study: a Randomized Evaluation of a New Smartphone-Based Support Tool to Increase Therapy Adherence of Patients with Acute Coronary SyndromeFlorian Krackhardt, Magnus Jörnten-Karlsson, Matthias Waliszewski, et al.
Lancet (London, England)|October 22, 2020
Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trialRaban V Jeger, Ahmed Farah, Marc-Alexander Ohlow, et al.
Journal of Cardiovascular Development and Disease|March 28, 2023
Impact of Insulin-Treated Compared to Non-Insulin-Treated Diabetes Mellitus on Outcome of Percutaneous Coronary Intervention with Drug-Coated Balloons versus Drug-Eluting Stents in De Novo Coronary Artery Disease: The Randomized BASKET-SMALL 2 TrialJulia Seeger, Jochen Wöhrle, Bruno Scheller, et al.
Clinical Cardiology|March 13, 2018
Drug-coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET-SMALL 2Nicole Gilgen, Ahmed Farah, Bruno Scheller, et al.
Lancet (London, England)|September 2, 2018
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trialRaban V Jeger, Ahmed Farah, Marc-Alexander Ohlow, et al.
American Heart Journal|January 15, 2019
Immediate unselected coronary angiography versus delayed triage in survivors of out-of-hospital cardiac arrest without ST-segment elevation: Design and rationale of the TOMAHAWK trialSteffen Desch, Anne Freund, Tobias Graf, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
JACC. Cardiovascular Interventions|August 20, 2021
Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents: The BASKET-SMALL 2 TrialJochen Wöhrle, Bruno Scheller, Julia Seeger, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 30, 2020
Drug-coated balloon versus drug-eluting stent in small coronary artery lesions: angiographic analysis from the BASKET-SMALL 2 trialGregor Fahrni, Bruno Scheller, Michael Coslovsky, et al.
Circulation. Cardiovascular Interventions|January 10, 2022
Safety and Efficacy of Drug-Coated Balloons Versus Drug-Eluting Stents in Acute Coronary Syndromes: A Prespecified Analysis of BASKET-SMALL 2Norman Mangner, Ahmed Farah, Marc-Alexander Ohlow, et al.
Cardiovascular Drugs and Therapy|April 20, 2022
Results from the "Me & My Heart" (eMocial) Study: a Randomized Evaluation of a New Smartphone-Based Support Tool to Increase Therapy Adherence of Patients with Acute Coronary SyndromeFlorian Krackhardt, Magnus Jörnten-Karlsson, Matthias Waliszewski, et al.
Lancet (London, England)|October 22, 2020
Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trialRaban V Jeger, Ahmed Farah, Marc-Alexander Ohlow, et al.
Journal of Cardiovascular Development and Disease|March 28, 2023
Impact of Insulin-Treated Compared to Non-Insulin-Treated Diabetes Mellitus on Outcome of Percutaneous Coronary Intervention with Drug-Coated Balloons versus Drug-Eluting Stents in De Novo Coronary Artery Disease: The Randomized BASKET-SMALL 2 TrialJulia Seeger, Jochen Wöhrle, Bruno Scheller, et al.
Clinical Cardiology|March 13, 2018
Drug-coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET-SMALL 2Nicole Gilgen, Ahmed Farah, Bruno Scheller, et al.
Lancet (London, England)|September 2, 2018
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trialRaban V Jeger, Ahmed Farah, Marc-Alexander Ohlow, et al.
American Heart Journal|January 15, 2019
Immediate unselected coronary angiography versus delayed triage in survivors of out-of-hospital cardiac arrest without ST-segment elevation: Design and rationale of the TOMAHAWK trialSteffen Desch, Anne Freund, Tobias Graf, et al.
Pageof 8